Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-8 of 8 for your search:
Drug:
brequinar
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
A Phase I/II Clinical Trial of Brequinar plus Fluorouracil in Patients with Refractory Solid Tumors (Summary Last Modified 08/91)
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Closed
Age:
18 to 80
Sponsor:
Protocol IDs:
YALE-HIC-5506
, NCI-V91-0051
2.
Phase II Chemotherapy with DuP-785 in Patients with Adenocarcinoma of the Pancreas (Summary Last Modified 06/89)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 to 75
Sponsor:
Protocol IDs:
EORTC-16871P
3.
Phase II Chemotherapy with DuP-785 in Patients with Advanced Breast Cancer (Summary Last Modified 03/89)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 to 74
Sponsor:
Protocol IDs:
EORTC-16871B
4.
Phase II Chemotherapy with DuP-785 in Patients with Advanced Colorectal Cancer (Summary Last Modified 03/89)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
19 to 74
Sponsor:
Protocol IDs:
EORTC-16871C
5.
Phase II Chemotherapy with DuP-785 in Patients with Advanced Renal Adenocarcinoma (Summary Last Modified 03/89)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 to 75
Sponsor:
Protocol IDs:
EORTC-16871K
6.
Phase II Chemotherapy with DuP-785 in Patients with Advanced Malignant Melanoma (Summary Last Modified 03/89)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 to 75
Sponsor:
Protocol IDs:
EORTC-16871M
7.
Phase II Chemotherapy with Brequinar Sodium (DuP 785) Administered on a Once-Weekly Schedule in Patients with Refractory Solid Tumors (Summary Last Modified 04/89)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 to 80
Sponsor:
Protocol IDs:
UNM-2088C
, NCI-V89-0021
8.
Phase II Chemotherapy with Brequinar Sodium (DuP 785) Administered on a Once-Weekly Schedule in Patients with Advanced Solid Tumors (Summary Last Modified 05/90)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 to 80
Sponsor:
Protocol IDs:
YALE-HIC-5218
, NCI-V89-0234
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute